Provided by Tiger Fintech (Singapore) Pte. Ltd.

BriaCell Therapeutics Corp.

3.84
+0.390011.30%
Post-market: 3.840.00000.00%19:26 EDT
Volume:62.14K
Turnover:230.54K
Market Cap:14.24M
PE:-0.29
High:3.89
Open:3.73
Low:3.45
Close:3.45
Loading ...

BriaCell Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Oct 2024

BriaCell’s Bria-IMT Regimen Shows Promise for Metastatic Breast Cancer with Brain Metastasis: A Buy Recommendation

TIPRANKS
·
03 Oct 2024

BriaCell Therapeutics Closes Offering of 5.13 Million Shares, Warrants

MT Newswires Live
·
03 Oct 2024

BRIEF-Briacell Therapeutics Announces Closing Of $5 Million Offering

Reuters
·
03 Oct 2024

BriaCell Therapeutics Announces Closing of $5 Million Offering

GlobeNewswire
·
03 Oct 2024

BriaCell Therapeutics Shares Plummet After Pricing of $5 Million Offering

MT Newswires Live
·
02 Oct 2024

BriaCell Therapeutics Launches $5 Million Offering

TIPRANKS
·
02 Oct 2024

BriaCell Therapeutics Announces $5 Million Offering

GlobeNewswire
·
02 Oct 2024

BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell

MT Newswires Live
·
01 Oct 2024

BriaCell reports anti-tumor response in patient treated in Phase 2 study

TIPRANKS
·
01 Oct 2024

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor

GlobeNewswire
·
01 Oct 2024

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock

Zacks
·
28 Sep 2024

Briacell Therapeutics Corp : H.c. Wainwright Cuts Target Price to $15 From $18

THOMSON REUTERS
·
19 Sep 2024

BriaCell Says FDA Greenlit Expanded Access Policy for Metastatic Breast Cancer Patients

MT Newswires Live
·
18 Sep 2024

BriaCell Offers New Hope for Breast Cancer Patients

TIPRANKS
·
18 Sep 2024

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients

GlobeNewswire
·
18 Sep 2024